Literature DB >> 9219783

Sphincter of Oddi dysfunction is associated with chronic pancreatitis.

P R Tarnasky1, B Hoffman, L Aabakken, W L Knapple, W Coyle, B Pineau, J T Cunningham, P B Cotton, R H Hawes.   

Abstract

OBJECTIVES: Chronic pancreatitis can be caused by ductal obstruction resulting from cicatricial papillary stenosis, but sphincter of Oddi motility studies have been inconclusive in patients with established chronic pancreatitis. We sought to determine whether there is an association between papillary sphincter dysfunction and changes of early chronic pancreatitis.
METHODS: Consecutive patients who underwent sphincter of Oddi manometry to investigate unexplained upper abdominal pain (n = 104) were assessed for evidence of chronic pancreatitis by pancreatic ductography, endoscopic ultrasound, and pancreatic fluid bicarbonate concentration.
RESULTS: Sphincter of Oddi dysfunction patients were four times more likely (odds ratio = 4.6) to have evidence of chronic pancreatitis than were those without sphincter dysfunction (p = 0.01). Of 68 patients with sphincter of Oddi dysfunction, 20 (29%) had structural evidence of chronic pancreatitis. Twenty of 23 (87%) patients with chronic pancreatitis had sphincter of Oddi dysfunction.
CONCLUSIONS: Sphincter of Oddi dysfunction is associated with changes of chronic pancreatitis in patients with unexplained pancreaticobiliary pain. Longitudinal follow-up is required to confirm these preliminary findings.

Entities:  

Mesh:

Year:  1997        PMID: 9219783

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  15 in total

Review 1.  Pathogenesis of pain in chronic pancreatitis: ongoing enigma.

Authors:  Philippus C Bornman; Israel N Marks; Andrew W Girdwood; Pascal O Berberat; Antanas Gulbinas; Markus W Büchler
Journal:  World J Surg       Date:  2003-10-27       Impact factor: 3.352

Review 2.  Endoscopic retrograde cholangiopancreatography in chronic pancreatitis.

Authors:  Peter J Bolan; Aaron S Fink
Journal:  World J Surg       Date:  2003-10-16       Impact factor: 3.352

3.  Pathological pancreatic exocrine function and duct morphology in patients with cholelithiasis.

Authors:  P D Hardt; L Bretz; A Krauss; H Schnell-Kretschmer; O Wusten; J Nalop; T Zekorn; H U Klör
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

Review 4.  [Sphincter of Oddi dyskinesia].

Authors:  H-D Allescher
Journal:  Internist (Berl)       Date:  2015-06       Impact factor: 0.743

Review 5.  Functional Pancreatic Sphincter Dysfunction in Children: Recommendations for Diagnosis and Management.

Authors:  Tom K Lin; Douglas S Fishman; Matthew J Giefer; Quin Y Liu; David Troendle; Steven Werlin; Mark E Lowe; Aliye Uc
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-12       Impact factor: 2.839

6.  Chronic Visceral Right Upper Quadrant Pain Without Gallstones.

Authors:  Sanjeeb Shrestha; Pankaj J. Pasricha
Journal:  Curr Treat Options Gastroenterol       Date:  2001-04

Review 7.  Gall stones and chronic pancreatitis: the black box in between.

Authors:  M-X Yan; Y-Q Li
Journal:  Postgrad Med J       Date:  2006-04       Impact factor: 2.401

8.  Endoscopic sphincterotomy in patients with stenosis of ampulla of Vater: three-year follow-up of exocrine pancreatic function and clinical symptoms.

Authors:  Nils Ewald; Axel Michael Marzeion; Reinhard Georg Bretzel; Hans Ulrich Kloer; Philip Daniel Hardt
Journal:  World J Gastroenterol       Date:  2007-02-14       Impact factor: 5.742

9.  Effect of somatostatin on the sphincter of Oddi in patients with acute non-biliary pancreatitis.

Authors:  K H Lai; G H Lo; J S Cheng; M T Fu; E M Wang; H H Chan; Y Y Wang; P I Hsu; C K Lin
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

10.  [Contrast-enhanced magnetic resonance cholangiography using gadolinium-EOB-DTPA. Preliminary experience and clinical applications].

Authors:  K Holzapfel; C Breitwieser; C Prinz; E J Rummeny; J Gaa
Journal:  Radiologe       Date:  2007-06       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.